The makers of Cialis want to sell a version of the popular erectile dysfunction drug over the counter. They expect to launch the OTC version on 2018.
The move is an effort to get a leg up on the competition from other Generic companies after it loses patent protection in 2017.
A large unmet demand exists for over-the-counter Cialis because many men suffering don’t feel comfortable talking to a doctor about the problem [company's position].
Lilly choose to partner with Sanofi due to their experience in gaining approval for over-the-counter versions of other drugs.
Marketing, selling, promoting, and in the process, blog the competition is just a process of renew the cash collection process.
First is the Brand prescription form and as the patent ending, now a new marketing program to block the generic. All in all, the customer[patient] are taken for a ride.
The system needs repair. If you have ED, that would not be the only thing you have. Your Heart [clinically] may be in the wrong place.
Just a [Hearty] thought.
No comments:
Post a Comment